CDK1-IN-6

• Description :

  CDK1-IN-6 (Ligand 3) is a potent CDK1 inhibitor. CDK1-IN-6 has the potential for the research of cancer[1].

• UNSPSC :

  12352211

• Target :

  CDK

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/cdk1-in-6.html

• Purity :

  99.96

• Smiles :

  CC1=CC=CC(NC2=CC(C3=CC=NC(N4CCOCC4)=C3)=CC=N2)=C1

• Molecular Formula :

  C21H22N4O

• Molecular Weight :

  346.43

• References & Citations :

  [1]Zuokun Lu, et al. Computational design of CDK1 inhibitors with enhanced target affinity and drug-likeness using deep-learning framework. Heliyon, 2024, 10 (22) .

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, stored under nitrogen, away from moisture)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  CDK1